{
    "nctId": "NCT01689610",
    "briefTitle": "Non-interventional Study With Nab-Paclitaxel (Abraxane\u00ae)",
    "officialTitle": "Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 705,
    "primaryOutcomeMeasure": "Time to Tumor Progression (TTP)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female Patients with metastatic breast cancer, who are at least 18 years old (no upper age limit)\n\nExclusion Criteria:\n\n* Contraindication according to the summary of product characteristics of Abraxane\u00ae\n* No signed patient informed consent form available\n* pregnant or breastfeeding patients.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}